Literature DB >> 2168340

Anti-viral immunity induced by recombinant nucleoprotein of influenza A virus. III. Delivery of recombinant nucleoprotein to the immune system using attenuated Salmonella typhimurium as a live carrier.

J P Tite1, X M Gao, C M Hughes-Jenkins, M Lipscombe, D O'Callaghan, G Dougan, F Y Liew.   

Abstract

A plasmid encoding the influenza nucleoprotein gene from A/NT/60/68 virus was transduced into the attenuated Salmonella typhimurium aroA- strain SL3261. The bacterial vector expressing the viral gene product was able to induce both humoral and cell-mediated immune responses to the nucleoprotein antigen. CD4+ virus-specific T cells capable of proliferation were readily induced and, in some circumstances, class II major histocompatibility complex (MHC)-restricted cytotoxicity was detected. However, virus-specific class I MHC-restricted cytotoxic T lymphocytes (CTL) were not detected after such immunization. Mice immunized orally with the nucleoprotein-expressing bacteria mounted a strong anti-viral antibody response and spleen cells from such mice proliferated specifically to virus challenge in vitro, producing interferon-gamma (IFN-gamma) and interleukin-2 (IL-2). Orally immunized mice showed significant protection from challenge infection with influenza virus if the mice were also boosted intranasally before infection.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2168340      PMCID: PMC1384261     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  18 in total

1.  Phagolysosome formation, cyclic adenosine 3':5'-monophosphate and the fate of Salmonella typhimurium within mouse peritoneal macrophages.

Authors:  M E Carrol; P S Jackett; V R Aber; D B Lowrie
Journal:  J Gen Microbiol       Date:  1979-02

2.  Immunology. The ins and outs of antigen processing and presentation.

Authors:  R N Germain
Journal:  Nature       Date:  1986 Aug 21-27       Impact factor: 49.962

3.  Differential expression of influenza N protein and neuraminidase antigenic determinants in Escherichia coli.

Authors:  I M Jones; G G Brownlee
Journal:  Gene       Date:  1985       Impact factor: 3.688

4.  Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo.

Authors:  S P Cobbold; A Jayasuriya; A Nash; T D Prospero; H Waldmann
Journal:  Nature       Date:  1984 Dec 6-12       Impact factor: 49.962

5.  Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines.

Authors:  S K Hoiseth; B A Stocker
Journal:  Nature       Date:  1981-05-21       Impact factor: 49.962

6.  Identification and characterization of T helper epitopes in the nucleoprotein of influenza A virus.

Authors:  X M Gao; F Y Liew; J P Tite
Journal:  J Immunol       Date:  1989-11-01       Impact factor: 5.422

Review 7.  Characterization of the murine antigenic determinant, designated L3T4a, recognized by monoclonal antibody GK1.5: expression of L3T4a by functional T cell clones appears to correlate primarily with class II MHC antigen-reactivity.

Authors:  D P Dialynas; D B Wilde; P Marrack; A Pierres; K A Wall; W Havran; G Otten; M R Loken; M Pierres; J Kappler
Journal:  Immunol Rev       Date:  1983       Impact factor: 12.988

8.  Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes.

Authors:  J W Yewdell; J R Bennink; G L Smith; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

9.  Monoclonal antibodies specific for Ia glycoproteins raised by immunization with activated T cells: possible role of T cellbound Ia antigens as targets of immunoregulatory T cells.

Authors:  C A Janeway; P J Conrad; E A Lerner; J Babich; P Wettstein; D B Murphy
Journal:  J Immunol       Date:  1984-02       Impact factor: 5.422

10.  Immunity to Salmonella typhimurium infection in C3H/HeJ and C3H/HeNCrlBR mice: studies with an aromatic-dependent live S. typhimurium strain as a vaccine.

Authors:  L M Killar; T K Eisenstein
Journal:  Infect Immun       Date:  1985-03       Impact factor: 3.441

View more
  22 in total

Review 1.  Recombinant avirulent salmonellae as oral vaccine carriers.

Authors:  F Schödel
Journal:  Infection       Date:  1992 Jan-Feb       Impact factor: 3.553

2.  Protective CD4+ and CD8+ T cells against influenza virus induced by vaccination with nucleoprotein DNA.

Authors:  J B Ulmer; T M Fu; R R Deck; A Friedman; L Guan; C DeWitt; X Liu; S Wang; M A Liu; J J Donnelly; M J Caulfield
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

3.  Control by H-2 genes of the Th1 response induced against a foreign antigen expressed by attenuated Salmonella typhimurium.

Authors:  R Lo-Man; P Martineau; E Dériaud; S M Newton; M Jehanno; J M Clément; C Fayolle; M Hofnung; C D Leclerc
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

4.  Antigen expressed by Salmonella typhimurium is processed for class I major histocompatibility complex presentation by macrophages but not infected epithelial cells.

Authors:  C V Harding; J D Pfeifer
Journal:  Immunology       Date:  1994-12       Impact factor: 7.397

5.  Expression of the murine interleukin-4 gene in an attenuated aroA strain of Salmonella typhimurium: persistence and immune response in BALB/c mice and susceptibility to macrophage killing.

Authors:  K Denich; P Börlin; P D O'Hanley; M Howard; A W Heath
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

6.  Protection of mice against an influenza virus infection by oral vaccination with viral nucleoprotein incorporated into immunostimulating complexes.

Authors:  K Scheepers; H Becht
Journal:  Med Microbiol Immunol       Date:  1994-11       Impact factor: 3.402

7.  Salmonella typhimurium delta aroA delta aroD mutants expressing a foreign recombinant protein induce specific major histocompatibility complex class I-restricted cytotoxic T lymphocytes in mice.

Authors:  S J Turner; F R Carbone; R A Strugnell
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

8.  Oral vaccination with an attenuated Salmonella typhimurium strain expressing Borrelia burgdorferi OspA prevents murine Lyme borreliosis.

Authors:  M Dunne; B K al-Ramadi; S W Barthold; R A Flavell; E Fikrig
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

9.  Construction, expression, and immunogenicity of the Schistosoma mansoni P28 glutathione S-transferase as a genetic fusion to tetanus toxin fragment C in a live Aro attenuated vaccine strain of Salmonella.

Authors:  C M Khan; B Villarreal-Ramos; R J Pierce; G Riveau; R Demarco de Hormaeche; H McNeill; T Ali; N Fairweather; S Chatfield; A Capron
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

10.  Immune responses to Streptococcus sobrinus surface protein antigen A expressed by recombinant Salmonella typhimurium.

Authors:  T A Doggett; E K Jagusztyn-Krynicka; R Curtiss
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.